Hyperuricemia

Febuxostat Not Associated With Increased Risks for CVD Events, All-Cause Mortality in Gout

Publish Date September 11, 2020

Researchers assessed whether febuxostat increased the risk of developing cardiovascular events, death from cardiac-cause, and all-cause mortalities.

Urate-Lowering Therapy May Reduce Type 2 Diabetes Risk in Patients With Gout

Publish Date September 2, 2020

Researchers investigated the association between gout, urate-lowering therapy use, and the risk of developing type 2 diabetes.

Adrenocorticotropic Hormone May Be an Alternative Therapeutic Option for Acute Gout

Publish Date August 19, 2020

Researchers evaluated the adrenocorticotropic hormone as an alternative therapeutic option for acute gout, and its potential mechanisms of action.

Urate-Lowering Therapy Reduces Ultrasound-Detected Crystal Load in Gout

Publish Date August 17, 2020

Patients with gout receiving urate lowering therapy by a treat-to-target approach demonstrate a reduced burden of monosodium urate crystals detected on ultrasound.

Increased Worldwide Burden of Gout From 1990 to 2017

Publish Date August 14, 2020

From 1990 to 2017, the burden of gout increased across the world.

Gout May Be Associated With Increased Risk for Epilepsy

Publish Date August 7, 2020

Researchers determined the association between gout and epilepsy and the risk for epilepsy in patients with gout.

Guideline-Concordant Gout Therapy Associated With Improved Arterial Function, Reduced Inflammation

Publish Date August 6, 2020

Researchers assessed whether initiating guideline-concordant gout therapy improved arterial function and reduced inflammation.

Increased Risk for Erectile Dysfunction in Patients With Gout

Publish Date July 24, 2020

Researchers investigated the association between gout and the risk for erectile dysfunction.

Allopurinol Found Not to Prevent Kidney Disease Progression in Key Populations

Publish Date June 25, 2020

In separate randomized controlled trials, allopurinol had no significant effect on kidney function decline.

Clinical Benefit Observed With Colchicine in Hospitalized COVID-19 Patients

Publish Date June 24, 2020

The open-label, prospective study (GRECCO-19) assessed the effect of treatment with low-dose colchicine on cardiac and inflammatory biomarkers as well as clinical outcomes.